Developing Streptomyces venezuelae as a cell factory for the production of small molecules used in drug discovery

Arch Pharm Res. 2015 Sep;38(9):1606-16. doi: 10.1007/s12272-015-0638-z. Epub 2015 Jul 28.

Abstract

The heterologous expression of biosynthetic pathways is an indispensable tool for drug discovery and development from natural products. Streptomyces venezuelae is a promising heterologous host as it offers several attractive advantages, such as rapid growth rate, convenient genetic manipulation, and an abundant supply of common biosynthetic building blocks. In recent decades, several S. venezuelae mutant strains have been constructed and used to facilitate the synthesis and derivatization of diverse natural products. In this review article, we have provided a schematic look at these host strains, which were used to synthesize natural products from genetically engineered biosynthetic gene clusters.

Keywords: Heterologous expression; Pathway engineering; S. venezuelae; Secondary metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Drug Discovery / methods*
  • Genetic Engineering / methods*
  • Humans
  • Streptomyces / genetics*
  • Streptomyces / metabolism*